Friday, March 29, 2024

Neurologist For Parkinson’s Disease

Predictors Of Specialist Care

Neurology – Topic 13 – Parkinson’s disease female patient

Only 58% of patients with PD saw a neurologist at any time in the 48-month study period. The remaining subjects received their PD care from a primary care physician specializing in internal medicine , family practice , or geriatric medicine . Some subjects had more than one type of primary care physician submit a PD treatment claim on their behalf. A logistic regression model including age, race, sex, modified comorbidity index, and socioeconomic deprivation score revealed that women and nonwhites were less likely to have specialist care. Specific race, sex, and age group data are presented in table 2. A multivariable regression model assessing the interaction of race and sex demonstrated that both factors strongly predicted whether a patient with PD received specialist care. Black female patients with PD were least likely to receive care by a neurologist in the study period , followed by black male and white female patients . Adjustment for comorbidity and socioeconomic variables did not alter race/sex relationships significantly, suggesting that race and sex are major predictors of specialist referral, after accounting for age. A sensitivity analysis using prevalent cases and the same covariates supported our findings with incident cases: women and blacks were less likely to have neurologist care, suggesting that referral was not merely delayed in early disease for these groups.

What Is A Datscan And What Role Does It Play In A Parkinsons Diagnosis

In 2011, the FDA approved the use of a scan called a dopamine transporter scan . A DaTscan is an imaging technology that allows visualization of the dopamine system in the brain. It is similar to an MRI, but looks at the function of the brain rather than the structure.

A DaTscan involves injection of a small amount of a radioactive drug that is then measured by a single-photon emission computed tomography scanner . The SPECT scanner measures the levels and location of the drug in the brain.

It is important to know that a negative DaTscan does not rule out PD, especially early in the disease, but a positive DaTscan can help confirm it. A positive DaTscan can differentiate PD from essential tremor as there is no dopamine deficiency in the latter. However, DaTscan abnormalities can be seen in PD as well as other forms of atypical parkinsonism that cause a loss of dopamine . This means that a positive result does not differentiate Parkinsons disease from other forms of atypical parkinsonism.

What Is Parkinson Disease

PD is named after James Parkinson, who first described the illness in 1817. PD mostly causes problems with movement. One of the most common problems that PD causes is called bradykinesia. This means that a person moves very slowly, almost like he or she is moving in slow motion. In addition, people with PD appear stiff or rigid. As they walk, they often have a slightly stooped posture. Their gait transforms into a very characteristic walking pattern. Patients shuffle their feet and take very small, frequent steps . At times, a person with PD may appear to suddenly freeze up or be unable to move for a short time. Someone who has PD will often have one or more of these symptoms.

A tremor of the hands is common, as well. In fact, this symptom, known as pill-rolling tremor, is the most characteristic physical finding in PD. It gets its name because of how the tremor looks. Many years ago, pharmacists used to make their own tablets. To make the medications into a pill, they would roll the medicine into a small round ball. The action that the pharmacist would use to roll the small balls looks similar to the tremor in PD.

Also Check: What Famous Person Has Parkinson’s Disease

Bwh: Comprehensive Treatment For Patients With Parkinson’s Disease

The Movement Disorder Program at BWH provides comprehensive evaluation and treatment for patients with movement disorders, including Parkinson’s disease, tremor, and dystonia . The Program’s team of physicians, nurses, and researchers is dedicated to advancing the understanding and treatment of Parkinson’s disease and related disorders. The Program is a collaboration between BWH and Massachusetts General Hospital working with the national Parkinson Study Group. In addition to Parkinson’s disease, the Program provides comprehensive care for patients with other movement disorders such as Tourette syndrome, tremor, and dystonia .

Research And Clinical Trials

Movement Disorders and Parkinsons Disease  Neurology in NHS Greater ...

OHSU scientists have long been at the forefront of research into Parkinsons disease. Over the years, we have played a role in every major development in Parkinsons care. Our work includes:

Clinical trials: The OHSU Brain Institute offers clinical trials for patients with varying stages of Parkinsons disease. We have research happening across many sites, so if you qualify, you may not need to travel to Portland to take part.

Parkinsons disease: We are conducting research on psychological and physical aspects of Parkinsons, including:

  • How stress affects the progression of the disease.
  • Ways to slow the breakdown of dopamine, a brain chemical that plays a central role in Parkinsons.
  • The role of protein buildup, with the goal of developing and testing a new medication.

Balance Disorders Laboratory: Researchers in our Balance Disorders Laboratory are exploring the connection between motor signals and balance to develop rehabilitation approaches.

Improving deep brain stimulation devices: DBS uses open-loop devices, which deliver constant stimulation even if symptoms are absent. Were exploring a closed-loop device to provide stimulation only as needed.

Recommended Reading: Copd And Parkinson’s Disease

Guideline For Treating Motor Symptoms Of Pd Gets First Update Since 2002

The guideline reflects findings regarding confidence in evidence about how to care for the motor symptoms in patients with early Parkinson disease , including the comparative efficacy of treatments as well as the comparative risk of adverse events.

The American Academy of Neurology updated 2002 guidelines regarding the treatment of motor symptoms with dopaminergic medications in patients with early-stage Parkinson disease , which has no disease-modifying therapy.

The guidelines, Neurology, the journal of the AAN, were created by a multidisciplinary panel after a systematic review of the latest evidence. They searched Medline, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov from database inception through June 2020 for relevant peer-reviewed articles, ultimately selecting 59 for the final analysis.

The guideline reflects the panels findings regarding confidence in evidence statements about how to care for the motor symptoms in patients with early PD, including the comparative efficacy of treatments as well as the comparative risk of adverse events.

Each therapy carries its own risk and benefit, the guidelines note. Levodopa is superior at reducing motor symptoms compared with either dopamine agonists or MAO-B inhibitors.

Likewise, the comparison of different formulations of dopamine agonists showed little evidence that any one formulation or method of administration is better than another.

Reference

Diagnosis Of Parkinsons Disease

The movement disorder specialists at Mount Sinai are expert in diagnosing and treating Parkinsons disease. There is no one test that diagnoses Parkinsons disease. Instead, we conduct a comprehensive history of symptoms and a detailed neurologic examination. After we confirm the diagnosis, we develop a comprehensive treatment plan, personalized to your needs.

Our neurosychologists and neuropsychiatrists evaluate patients who are being considered for certain medications or treatments , provide support and counseling, and oversee treatments and strategies for dealing with mood, memory, or other challenges.

Read Also: Steroids And Parkinson’s Disease

Parkinson’s Patients Do Best If Treated By Neurologist

Study Shows Parkinson’s Patients Cared for by Neurologists Are Less Likely to Be Put in Nursing Homes

Aug. 10, 2011 — People with Parkinson’s disease may live longer if treated by a neurologist, a new study suggests.

The study also found that Parkinson’s patients who see a neurologist are less likely to be placed in a nursing home and less likely to break a hip.

The study is published in Neurology.

“This is a very interesting and unique investigation,” Washington University researcher Allison Wright Willis, MD, tells WebMD. “There are ways that we can help improve the lives of people with Parkinson’s disease beyond discovering a cure and beyond discovering the cause.”

Researchers analyzed the records of nearly 138,000 newly diagnosed Parkinson’s disease patients receiving Medicare seen in outpatient clinics during 2002. Between 2002 and 2005, 58% of them were treated by neurologists.

The fact that more than half of Parkinson’s patients are already seeing a neurologist for treatment is reassuring to James C. Beck, PhD, director of research programs at the Parkinson’s Disease Foundation.

“But that still leaves a large number, over 40%, who are not seeing a neurologist for their care,” Beck tells WebMD. Beck was not involved in the study.

The study revealed that women are 22% less likely than men to see a neurologist, and minorities are 17% less likely than whites to see a neurologist.

Beyond Symptomatic Therapy: Neuroprotection Studies In Pd

Neurology – Topic 14 – Parkinsons disease – examining a patient

Neuroprotective therapies are interventions that produce enduring benefits by favorably influencing the underlying etiology or pathogenesis of neurodegenerative disorders . Although there is currently no definitive methodology to assess neuroprotection in PD patients , multiple attempts have been made to assess the effects of medications on disease progression.

You May Like: Diet For Parkinson Disease Patient

How Is Parkinson’s Disease Treated

There is no single treatment for Parkinsons Disease and your neurologist will work with you to develop an individual plan for your ongoing treatment and care. While there is no known cure for Parkinsons Disease the goal of your neurologist is to control your symptoms and increase your quality of life. Treatment options include medication, surgery, and therapy and lifestyle modifications, which include exercise and rest, physical therapy, support groups, occupational therapy and speech therapy.

If you have been diagnosed with Parkinsons Disease, or you have the primary symptoms associated with Parkinsons Disease, you should know that studies show that patients with Parkinsons Disease do best if they are treated by a neurologist. At our office our neurologists can diagnose and treat patients with Parkinsons Disease in Los Angeles and Santa Monica. To make an appointment with a Parkinsons specialist contact us to schedule an appointment at .

What Is The Outlook For Persons With Parkinsons Disease

Although there is no cure or absolute evidence of ways to prevent Parkinsons disease, scientists are working hard to learn more about the disease and find innovative ways to better manage it, prevent it from progressing and ultimately curing it.

Currently, you and your healthcare teams efforts are focused on medical management of your symptoms along with general health and lifestyle improvement recommendations . By identifying individual symptoms and adjusting the course of action based on changes in symptoms, most people with Parkinsons disease can live fulfilling lives.

The future is hopeful. Some of the research underway includes:

  • Using stem cells to produce new neurons, which would produce dopamine.
  • Producing a dopamine-producing enzyme that is delivered to a gene in the brain that controls movement.
  • Using a naturally occurring human protein glial cell-line derived neurotrophic factor, GDNF to protect dopamine-releasing nerve cells.

Many other investigations are underway too. Much has been learned, much progress has been made and additional discoveries are likely to come.

Recommended Reading: Prayers For Parkinsons Disease

You May Like: Velvet Beans For Parkinson’s Disease

Tapering And Discontinuing Das

Recommendation 5 Rationale

Adverse effects associated with DAs can lead to substantial impairments in psychosocial functioning, interpersonal relationships, and quality of life for the patient and caregivers. The consequences of medication-related adverse effects may be mitigated through adjustments to prescribed medications, including DAs, or through additional behavioral or pharmacologic interventions, if appropriate.

Patients may experience undesirable side effects when attempting to decrease dopaminergic medications, especially DAs, including dopamine agonist withdrawal syndrome or low mood and apathy. These side effects can make it difficult to taper or discontinue DAs. Staged reduction in dosing may reduce the severity of withdrawal symptoms and improve compliance with medication recommendations.

Recommendation 5 Statements

  • 5a. Clinicians should recommend tapering or discontinuation of DAs if patients experience disabling medication-related adverse effects, including ICDs, EDS, sudden-onset sleep, cognitive impairment, or hallucinations .

  • 5b. When DAs must be discontinued due to adverse effects, clinicians should monitor patients for symptoms of DAWS and, when possible, gradually decrease the dosage to minimize symptoms .

Accurate Parkinsons Disease Diagnosis

7 Secondary Symptoms of Parkinson

Parkinsons is challenging to diagnose because symptoms, such as difficulty walking, can be a sign of other movement disorders. Some people have parkinsonism. This group of diseases causes Parkinsons-like symptoms that do not respond to Parkinsons treatments.

At Cedars-Sinai, we consider your health history and perform a nervous system exam before confirming a Parkinsons diagnosis. Our years of experience enable us to detect subtle symptoms that do not show up on other tests.

Tests may include:

Levodopa Testing

Testing your response to a Parkinsons drug, levodopa, allows us to rule out some other movement disorders. Levodopa boosts dopamine levels and is not an effective treatment for other movement disorders. If your symptoms improve with levodopa, you likely have Parkinsons.

DaTscan Test

We may use this noninvasive imaging test to help rule out Parkinsonian syndrome. This group of disorders causes movement problems similar to Parkinsons but might not stem from the disease. Learn more about DaTscan.

Read Also: How Long Do Elderly Live With Parkinson’s

Communicating With Your Doctor

One of the most important parts of getting good medical care is communicating with your doctor and health care team, so you can make smart, informed decisions about your health. That includes getting detailed information about your condition, how it can be treated, what the possible side effects of different treatment options are, and what you can do to improve your quality of life. It also includes information about coping with your diagnosis and treatment, both emotionally and physically.

Risk Factors For Parkinsons Disease

While a primary cause for PD is not yet known, certain risk factors can increase a persons likelihood of developing the disease:

  • Age: PD is rare in young people. People who develop the disease are usually around 60 or older, and the risk increases with age.
  • Exposure to environmental toxins: Exposure to certain herbicides and pesticides can increase risk.
  • Gender: Men are more likely to develop PD than women. On average, three men will develop the disease for every two women.
  • Heredity: Having a close relative with PD increases the chances of developing the disease. However, that risk is still small unless family members develop the disease at a young age.

You May Like: Names Of Parkinson’s Medication

Is Your Doctor Right For You

The first step is finding a qualified physician. Each type of insurance is different, but typically you will be required to be referred to a specialist such as a neurologist by your primary care doctor. If your symptoms warrant it, your doctor can refer you to a neurologist. This neurologist may decide that you should see a neurologist who is a Movement Disorder Specialist. If you have a preference as to which MDS you would most like to be seen by, be sure to discuss this with the doctor who is writing your referral order. In outlying areas where there are no MDS to see, try to at least be seen by a neurologist.

The second step is considering whether the neurologist or Movement Disorder Specialist is the right one for you. You should feel comfortable in this relationship and feel that you and the MDS are a good match.

What Is Parkinsons Disease

Approach to the Exam for Parkinson’s Disease

Parkinsons Disease is a chronic and progressive movement disorder, which is the result of a loss of dopamine-producing brain cells. Over 1,000,000 people in the United States have Parkinsons Disease and 50,000-60,000 new cases of Parkinsons are diagnosed every year. There is no known cure for Parkinsons Disease, but a number of medications, therapy and surgery may provide patients with relief from some symptoms.

The most common type of Parkinsons Disease is known as late-onset disease which begins after age 50. If signs and symptoms begin before age 50 the condition is described as early-onset disease. Early-onset cases that begin before age 20 are sometimes referred to as juvenile-onset Parkinson disease.

If you would like to learn more, read on or schedule a consultation with our Los Angeles Parkinsons specialists.

You May Like: How To Improve Parkinson’s Gait

Movement Disorder Specialists Work With You To Create A Personalized Treatment Plan

Movement disorder specialists training and experience make them ideal doctors to develop a plan for treating and managing symptoms, as well as help you or your loved one live well throughout the course of Parkinsons disease.

Your movement disorder specialist can:

  • Manage Parkinsons disease medications and potential side effects
  • Recommend and perform botulinum toxin injections, which can help with symptoms such as drooling or limb dystonia
  • Treat and manage non-motor symptoms such as depression, constipation, low blood pressure and sleep disturbances
  • Evaluate you for deep brain stimulation or other invasive Parkinsons therapies, and manage your care after the procedure

But one of the most important aspects of a movement disorder specialists role should be coordinating care with other specialists such as:

Movement Disorder Treatments We Offer

Theres no cure for movement disorders. But several treatments can significantly reduce symptoms and improve quality of life. Our neurologists provide a variety of treatments for movement disorders, including:

  • Medications: Certain medicines may help interrupt the nerve signals that cause muscle spasms.
  • Occupational therapy : OT can help patients increase fine motor skills and complete daily tasks such as brushing their teeth, bathing or grooming.
  • Physical therapy : PT involves specific exercises to help patients increase strength, balance and muscle tone.
  • Botulinum toxin injections: A neurologist may administer a botulinum toxin injection directly to the affected muscle. The medication interrupts the nerve signals that cause muscle spasms and reduces symptoms.
  • Deep brain stimulation: Not everyone needs deep brain stimulation, but it can help those with severe or complex symptoms. A neurosurgeon places electrodes on the brain. These electrodes connect to an implantable device. The device sends messages to the electrodes to interrupt and stop the nerve signals that cause uncontrollable movements.

Recommended Reading: List Of Parkinson’s Medications

Popular Articles
Related news